SE9802546D0 - Medicinal product and method for treatment and prevention of dyskinesia - Google Patents

Medicinal product and method for treatment and prevention of dyskinesia

Info

Publication number
SE9802546D0
SE9802546D0 SE9802546A SE9802546A SE9802546D0 SE 9802546 D0 SE9802546 D0 SE 9802546D0 SE 9802546 A SE9802546 A SE 9802546A SE 9802546 A SE9802546 A SE 9802546A SE 9802546 D0 SE9802546 D0 SE 9802546D0
Authority
SE
Sweden
Prior art keywords
dyskinesia
prevention
treatment
medicinal product
dystonia
Prior art date
Application number
SE9802546A
Other languages
Swedish (sv)
Inventor
Ross Nicholas Waters
Arvid Carlsson
Clas Aake Sonesson
Joakim Tedroff
Original Assignee
Ross Nicholas Waters
Arvid Carlsson
Clas Aake Sonesson
Joakim Tedroff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ross Nicholas Waters, Arvid Carlsson, Clas Aake Sonesson, Joakim Tedroff filed Critical Ross Nicholas Waters
Priority to SE9802546A priority Critical patent/SE9802546D0/en
Publication of SE9802546D0 publication Critical patent/SE9802546D0/en
Priority to BR9912051-8A priority patent/BR9912051A/en
Priority to PCT/SE1999/001274 priority patent/WO2000003714A1/en
Priority to EP99940783A priority patent/EP1096935A1/en
Priority to JP2000559849A priority patent/JP2002520361A/en
Priority to AU54568/99A priority patent/AU5456899A/en
Priority to CA002336998A priority patent/CA2336998A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Abstract

The invention relates to use of compounds according to formula (I), wherein n preferably is 2; R1 preferably is SO2CH3, R2 preferably is H, and R3 preferably is a C1-C8 alkyl, or pharmaceutically acceptable salts thereof for the production of a medicinal product for treatment and/or prevention of dyskinesia such as dystonia, tremor or chorea. The invention also relates to methods for treatment and prevention of dyskinesia such as dystonia, tremor or chorea, said method comprising administration of a compound according to formula (I).
SE9802546A 1998-07-15 1998-07-15 Medicinal product and method for treatment and prevention of dyskinesia SE9802546D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9802546A SE9802546D0 (en) 1998-07-15 1998-07-15 Medicinal product and method for treatment and prevention of dyskinesia
BR9912051-8A BR9912051A (en) 1998-07-15 1999-07-15 Use of compost, and, process for treatment and prevention of dyskinesia.
PCT/SE1999/001274 WO2000003714A1 (en) 1998-07-15 1999-07-15 Medicinal product and method for treatment and prevention of dyskinesia
EP99940783A EP1096935A1 (en) 1998-07-15 1999-07-15 Medicinal product and method for treatment and prevention of dyskinesia
JP2000559849A JP2002520361A (en) 1998-07-15 1999-07-15 Medicinal substances and methods for treating, protecting and preventing dyskinesia
AU54568/99A AU5456899A (en) 1998-07-15 1999-07-15 Medicinal product and method for treatment and prevention of dyskinesia
CA002336998A CA2336998A1 (en) 1998-07-15 1999-07-15 Medicinal product and method for treatment and prevention of dyskinesia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9802546A SE9802546D0 (en) 1998-07-15 1998-07-15 Medicinal product and method for treatment and prevention of dyskinesia

Publications (1)

Publication Number Publication Date
SE9802546D0 true SE9802546D0 (en) 1998-07-15

Family

ID=20412091

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9802546A SE9802546D0 (en) 1998-07-15 1998-07-15 Medicinal product and method for treatment and prevention of dyskinesia

Country Status (7)

Country Link
EP (1) EP1096935A1 (en)
JP (1) JP2002520361A (en)
AU (1) AU5456899A (en)
BR (1) BR9912051A (en)
CA (1) CA2336998A1 (en)
SE (1) SE9802546D0 (en)
WO (1) WO2000003714A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE46117E1 (en) 1999-12-22 2016-08-23 Teva Pharmaceuticals International Gmbh Modulators of dopamine neurotransmission
GB0002100D0 (en) * 2000-01-28 2000-03-22 Novartis Ag Organic compounds
WO2002056745A2 (en) * 2000-10-12 2002-07-25 Pharmacia & Upjohn Company Method of treating parkinson's disease
AR031152A1 (en) 2000-10-31 2003-09-10 Upjohn Co NEW TREATMENTS FOR THE CONCERNED LEG SYNDROME
US6670378B2 (en) * 2001-05-08 2003-12-30 Pharmacia & Upjohn Company Method of treating Parkinson's disease
DK2618826T3 (en) * 2010-09-20 2016-08-01 A Carlsson Res Ab Phenylpiperdine FOR TREATMENT OF DEMENTIA

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR72841B (en) * 1979-12-05 1983-12-07 Carlsson Arvid Emil
US4937346A (en) * 1979-12-05 1990-06-26 Per Arvid Emil Carlsson Phenyl-azacykloalkanes
US4719219A (en) * 1982-03-30 1988-01-12 Per A. E. Carlsson Phenyl-azacycloalkanes and use thereof in treatment of central nervous system disorders

Also Published As

Publication number Publication date
WO2000003714A1 (en) 2000-01-27
EP1096935A1 (en) 2001-05-09
CA2336998A1 (en) 2000-01-27
JP2002520361A (en) 2002-07-09
BR9912051A (en) 2001-04-03
AU5456899A (en) 2000-02-07

Similar Documents

Publication Publication Date Title
MX9604020A (en) Arylalkyldiazinones.
MY140525A (en) Pharmaceutical uses for alpha2delta ligands
TW369535B (en) A pyrazolopyridine compound and the process for preparing thereof
HU9603433D0 (en) Novel 4-6-diaryl-pyrimidine-derivatives and salts thereof
EP0970954A4 (en) 3-piperidyl-4-oxoquinazoline derivatives and medicincal compositions containing the same
CA2328780A1 (en) Dihydropyrimidines
RU94036772A (en) Application of 2-phenyl-3-aroylbenzothiophenes for endometriosis inhibition
HUP9802762A2 (en) Diphenylmethylene piperidine derivatives, pharmaceutical compositions containing them, process for producing them and their use
EA200101077A1 (en) COMPOSITION FOR PREVENTION OR TREATMENT OF WEAKNESS, INCLUDING A HYDROXICORIC ACID DERIVATIVE OR EXTRACT OF ANGELICAE GENERA PLANT, CONTAINING IT
CA2238845A1 (en) Novel 2,3,5-trimethyl-4-hydroxy anilide derivatives, preparation thereof and therapeutical use thereof
WO1999012532A3 (en) Piperidine derivatives against malaria
RU94044453A (en) Use of 2-phenyl-3-aroylbenzothiophenes for seborrhea and acne inhibition
NO944915L (en) Increase in thrombomodulin expression
BR9506552A (en) Retroviral integrase inhibition method
MD1560G2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses
SE9802546D0 (en) Medicinal product and method for treatment and prevention of dyskinesia
SE9702716D0 (en) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
HU910784D0 (en) Process for producing new urea derivatives as well as pharmaceutical preparatives containing these compounds as active substance
CA2347939A1 (en) Composition for the treatment of rheumatism, hepatitis or pancreatitis
AU6257396A (en) Tetrahydrofuran antifungals
ATE267832T1 (en) SUBSTANCE GM-95, METHOD FOR PRODUCTION THEREOF AND USE THEREOF
NO20003138L (en) New application of local anesthetics to vascular headaches
HUP0003023A2 (en) (s) 2-methylamino-2-phenyl-n-butyl 3,4,5-trimethoxybenzoate, its application to the treatment of chronic pain
MX9800705A (en) Heterocyclic compounds for treating myocardial ischaemia.
AU2002212241A1 (en) Method for producing chiral compounds